Prevention of Bone Events
We recommend
Osteonecrosis of the Jaw Associated with Antiresorptive Pharmacotherapy in Oncological Patients
Antiresorptive pharmacotherapy in the form of bisphosphonates and denosumab is associated, according to current knowledge, with the risk of jaw osteonecrosis, especially following dental procedures such as tooth extractions. The aim of the newly published systematic review was therefore to evaluate the incidence of this complication following dental extractions in connection with the administration of antiresorptive medication and to identify risk factors for jaw osteonecrosis in oncological patients.
Prediction of Hypocalcemia Risk in Patients Treated with Denosumab and Active Form of Vitamin D
According to new work by Japanese authors, it appears that the risk factors for the development of…
Rebound effect after denosumab discontinuation in a patient with lung cancer
The case study of a patient with metastatic lung cancer describes the emergence of vertebral…
Articles on this topic
Prevention of Symptomatic Skeletal Events in Postmenopausal Women with Advanced ER-Positive Breast Cancer
Advanced breast cancer with the presence of estrogen receptors is one of the most common…
How to Most Effectively Delay Skeletal Events in Patients with Bone Metastases from Solid Tumors?
In a randomized Phase III study, the effectiveness of denosumab and zoledronic acid in…
Effect of Denosumab and Zoledronic Acid on Overall Survival in Patients with Metastatic Lung Cancer
In 30-40% of patients with non-small cell lung cancer (NSCLC), bone metastases develop during…
Prevention of Skeletal Events in the Therapy of Patients with Advanced Prostate Cancer
Prostate cancer most commonly forms metastases in the bones. In patients with this advanced…
Curative Potential of Neoadjuvant Denosumab in the Treatment of Giant Cell Spinal Tumor? A Case Study
Portuguese authors present a case study of a young woman diagnosed with a giant cell spinal…
Subscribe
Most read on this topic
Journal on this topic
Related topic
Most read on this topic
- Prevention of Skeletal Events in the Therapy of Patients with Advanced Prostate Cancer
- Osteonecrosis of the Jaw Associated with Antiresorptive Pharmacotherapy in Oncological Patients
- How to Most Effectively Delay Skeletal Events in Patients with Bone Metastases from Solid Tumors?
- Readmission and complication rates in patients undergoing PCNL, stratified by co-morbid factors
- Rebound effect after denosumab discontinuation in a patient with lung cancer
- Prediction of Hypocalcemia Risk in Patients Treated with Denosumab and Active Form of Vitamin D
Journal on this topic
Related topic